Filing Details

Accession Number:
0001178913-11-002068
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-07-21 17:24:04
Reporting Period:
2011-01-14
Filing Date:
2011-07-21
Accepted Time:
2011-07-21 17:24:04
Original Submission Date:
2011-03-15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1321502 Andain Inc. ANDN Pharmaceutical Preparations (2834) 202066406
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1324761 Howie Fialkov 3845 Bathurst Street, Suite 202
Toronto, Ontario CA M3H 3N2
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-14 850,000 $0.00 3,051,800 No 4 P Indirect Control of 1568934 Ontario Limited
Common Stock Acquisiton 2011-01-14 266,667 $0.75 3,318,467 No 4 P Indirect Control of 1568934 Ontario Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Control of 1568934 Ontario Limited
No 4 P Indirect Control of 1568934 Ontario Limited
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 01/14/2011 Acquisiton 2011-01-14 1 $0.00 1,000,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1 2011-04-11 2013-04-11 No 4 J Indirect
Footnotes
  1. 1568934 Ontario Limited entered into a stock purchase agreement dated January 14, 2011 to purchase 850,000 shares of common stock from Pangea Investments GmbH, another affiliate of the issuer.
  2. 1568934 Ontario Limited entered into a Regulation S Stock Purchase Agreement dated January 14, 2011 to purchase 266,667 shares of common stock from the issuer.
  3. This stock option was issued in connection with the above mentioned Regulation S Stock Purchase Agreement.
  4. Exercisable for a period of 24 months from the issuer's Form 15c2-11 filing with FINRA.
  5. Exercisable at a price that is equal to the public offering price of the issuer's common stock in a future Form S-1 registration statement.